GSA Capital Partners’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $595K | Buy |
+240,011
| New | +$595K | 0.04% | 800 |
|
|
2024
Q3 | – | Sell |
-16,814
| Closed | -$78K | – | 1600 |
|
|
2024
Q2 | $78K | Buy |
+16,814
| New | +$78K | 0.01% | 1545 |
|
|
2022
Q4 | – | Sell |
-22,486
| Closed | -$38K | – | 1470 |
|
|
2022
Q3 | $38K | Buy |
+22,486
| New | +$38K | 0.01% | 1436 |
|
|
2021
Q4 | – | Sell |
-69,299
| Closed | -$586K | – | 1412 |
|
|
2021
Q3 | $586K | Sell |
69,299
-3,547
| -5% | -$30K | 0.06% | 605 |
|
|
2021
Q2 | $888K | Buy |
72,846
+51,646
| +244% | +$630K | 0.1% | 307 |
|
|
2021
Q1 | $514K | Buy |
+21,200
| New | +$514K | 0.09% | 338 |
|